References
- National Cancer Institute. Genetic Testing for BRCA1 and BRCA2: It is Your Choice. Available online at: http://www.cancer.gov/cancertopics/factsheet/Risk/BRCA. Last Accessed 12/02/08.
- Lindor NM, McMastor ML, Lindor CJ, Greene MH. The concise handbook of familial cancer susceptibility syndromes, 2nd ed. J Natl Cancer Inst. Monographs. 2008;38:22–29.
- Fatouros M, Baltoyiannis G, Roukos DH. The predominant role of surgery in the prevention and new trends in the surgical treatment of women with BRCA1/2 mutations. Ann Surg Oncol. 2007;15(1):21–33.
- Nusbaum R, Isaacs C. Management updates for women with BRCA1 or BRCA2 mutation. Mol Diag Ther. 2007;11(3):133–144.
- Frelick RW, Strusowski P, Petrelli N, Grusenmeyer P. Oncology nurse care coordinators as “navigators”: Improving cancer disease management and patient experience. Oncol Issues. July/August 2006;20(4):26–30.
- Grusenmeyer PA, Petrelli NJ, Strusowski P. Developing and operating multidisciplinary disease-specific clinics. Community Oncology. June 2006; 3(6):385–387.
- National Comprehensive Cancer Network. Genetic/familial high-risk assessment: breast and ovarian. NCCN Clinical Practice Guidelines in Oncology-V.I.2008. Available online at: http://www.nccn.org/professionals/physician_gls/PDF/genetics_screening.pdf Last accessed 12/02/08.
- Pavelka JC, Andrew JL, Karlan BY. Hereditary ovarian cancer – assessing risk and prevention strategies. Obstet Gynecol Clin NAM. 2007;34:651–665.
- Bober SL, Hoke LA, Duda RB, Tung NM. Recommendation recall and satisfaction after attending breast/ovarian cancer risk counseling. J Genet Counsel. 2007;16:755–762.